Option Care Health, Inc. (NASDAQ:OPCH) Stake Reduced by Amalgamated Bank

Amalgamated Bank trimmed its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 6.9% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 78,421 shares of the company’s stock after selling 5,803 shares during the quarter. Amalgamated Bank’s holdings in Option Care Health were worth $2,455,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Thrivent Financial for Lutherans grew its holdings in Option Care Health by 9.1% in the 2nd quarter. Thrivent Financial for Lutherans now owns 5,459,119 shares of the company’s stock worth $151,218,000 after buying an additional 455,310 shares in the last quarter. Westfield Capital Management Co. LP grew its stake in shares of Option Care Health by 15.4% in the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock worth $173,448,000 after purchasing an additional 688,653 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Option Care Health by 6.5% during the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock valued at $99,870,000 after purchasing an additional 218,844 shares during the period. Magnetar Financial LLC raised its stake in shares of Option Care Health by 124.8% during the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock valued at $68,750,000 after purchasing an additional 1,377,929 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA acquired a new stake in Option Care Health in the second quarter worth about $68,003,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analysts Set New Price Targets

OPCH has been the topic of several research analyst reports. Truist Financial lowered their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. JMP Securities raised their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, Barrington Research lowered their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and an average price target of $30.83.

Insider Activity

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares in the company, valued at $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by company insiders.

Option Care Health Price Performance

NASDAQ OPCH opened at $22.86 on Tuesday. The stock has a market capitalization of $3.89 billion, a P/E ratio of 19.21, a P/E/G ratio of 2.33 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The business’s fifty day moving average is $29.43 and its two-hundred day moving average is $29.59. Option Care Health, Inc. has a 1 year low of $22.25 and a 1 year high of $34.63.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.